Oral GLP-1 RAs are also under development, and early data show similar weight loss efficacy to semaglutide 2.4 mg [84], which could improve convenience and potentially reduce costs through improved manufacturing and distribution efficiency
Used syringes and needles should be placed in a sharps container
Recombinant human GLP-1 beinaglutide regulates lipid metabolism of adipose tissues in diet-induced obese mice
One AssuredPartners case study found GLP1 users saved about $560 per person per year in medical costs but against an average annual drug cost of $6,540, the nearterm ROI is negative for most employers
Injection site reactions such as redness, itching, swelling, or mild pain can occur with GLP-1 medications and are usually mild and transient
When appetite suppression stays mild, patients can still eat enough protein and maintain proper training intensity